Skip to main content

and
  1. No Access

    Article

    Epidemiologie, Ätiologie und Prävention des Zervixkarzinoms

    A. Schneider, M. Dürst, S. J. Klug, A. Kaufmann, I. Jochmus, L. Gissmann in Der Onkologe (2001)

  2. No Access

    Article

    E7-specific cytotoxic T cell tolerance in HPV-transgenic mice

    The “high-risk” human papillomavirus type 16 (HPV 16) is associated with the development of cervical cancer. Although the viral gene products E6 and E7 are constitutively expressed in HPV 16-associated lesions...

    A. Borchers, J. Braspenning, J. Meijer, W. Osen, L. Gissmann in Archives of Virology (1999)

  3. Article

    Epidemiologie, Ätiologie und Prävention des Zervixkarzinoms

    Durch molekulare und epidemiologische Studien wurde bewiesen, daß die humanpathogenen Papillomviren (HPV) Typ 16 und 18 ursächlich an der Entstehung des Zervixkarzinoms beteiligt sind. Diese Aussage gilt auch ...

    A. Schneider, M. Dürst, I. Jochmus, L. Gissmann in Der Gynäkologe (1999)

  4. No Access

    Article

    Epidemiologie, Ätiologie und Prävention des Zervixkarzinoms

    A. Schneider, M. Dürst, I. Jochmus, L. Gissmann in Der Onkologe (1998)

  5. No Access

    Article

    Human papillomavirus type 16 (HPV 16) E7 and major histocompatibility complex (MHC) class I and II expression in human keratinocytes in culture

    The low expression of major histocompatibility complex (MHC) class I antigens on human papillomavirus (HPV)-infected cervical carcinoma cells may be responsible for an insufficient cytotoxic T cell response ag...

    A. Hoos, C. D'Incan, L. Gissmann, A. Altmann, F. Momburg, I. Nindl in Archives of Virology (1996)

  6. No Access

    Chapter and Conference Paper

    Antibodies to the Human Papillomavirus 16 and 18 E7 Proteins: A Possible Diagnostic Marker for Cervical Cancer

    Human papillomavirus (HPV) types 16 and 18 belong to a heterogeneous group of epitheliotropic viruses which induce benign proliferations of the skin or mucosa (for review, see de Villiers 1989). During the pas...

    M. Müller, I. Jochmus, C. Bleul, K. V. Shah, R. K. Viscidi, L. Gissmann in Cancer Diagnosis (1992)